Shareholder Tools

Press Releases

2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 1999
Press Releases
Date Title and Summary View
Dec 13, 2011 Analyses Confirm Greatest Benefit in FR(++) Population Conference Call/Webcast at 8:30 a.m. EST Today WEST LAFAYETTE, Ind., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized th...
Nov 18, 2011 WEST LAFAYETTE, Ind., Nov. 18, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:^NBI) as part of NAS...
Nov 10, 2011 WEST LAFAYETTE, Ind., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates and companion imaging diagnostics for personalized therapy, today announced financial results for the third quarter ending September 30, 2011, and provided an operational update. ...
Nov 3, 2011 WEST LAFAYETTE, Ind., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that the company will host a conference call on Thursday, November 10, 2011, at 4:30 PM Eastern Standa...
Oct 14, 2011 WEST LAFAYETTE, Ind., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Mike Sherman, chief financial officer of Endocyte, will present at the upcoming 18th Annual News...
Sep 8, 2011 WEST LAFAYETTE, Ind., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that a poster about its EC-FV-04 study will be presented at the 17th International Meeting of the Eur...
Aug 31, 2011 WEST LAFAYETTE, Ind., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Ron Ellis, president and CEO of Endocyte, will be presenting at two upcoming investor conference...
Aug 23, 2011 WEST LAFAYETTE, Ind., Aug. 23, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that the company's proprietary design strategies for the synthesis of SMDCs will be outlined in six p...
Aug 11, 2011 -  EU Marketing Authorization Application Filing for EC145 and EC20 in Platinum-Resistant Ovarian Cancer Expected in the First Quarter of 2012 -  Phase 2 Trial of EC145 in Non-Small Cell Lung Cancer Expected to Initiate in the First Quarter of 2012 WEST LAFAYETTE, Ind., Aug. 11, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT),...
Aug 10, 2011 WEST LAFAYETTE, Ind., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Ron Ellis, President and CEO of Endocyte, will present at the upcoming 2011 Life Sciences Manage...
1
NextLast
Add to Briefcase = add release to Briefcase